Bosentan prevents preglomerular alterations during angiotensin II hypertension

Hypertension

Volumn 30, Issue 6, 1997, Pages 1613-1620

  Casellas, Daniel ^a   Bouriquet, Nathalie ^a   Herizi, Abderraouf ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

Autoregulation; Basal tone; Endothelin; Glomerulopathy; Nephrons

Indexed keywords

ANGIOTENSIN; BOSENTAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOREGULATION; BLOOD PRESSURE MONITORING; CELL PROLIFERATION; GLOMERULUS BASEMENT MEMBRANE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; SYSTOLIC BLOOD PRESSURE;

EID: 0030722999     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.6.1613     Document Type: Article

References (41)

1. Simon G, Abraham G. Angiotensin II administration as an experimental model of hypertension. In: Hypertension: Pathophysiology, Diagnosis, and Management, ed 2. New York, NY: Raven Press; 1995:1423-1435.
2. Hall JE, Guyton AC, Brands MW. Pressure-volume regulation in hypertension. Kidney Int. 1996;49(suppl 55):S35-S41.
3. Ploth DW. Angiotensin-dependent renal mechanisms in two- kidney, one-clip renal vascular hypertension. Am J Physiol. 1983; 245:F131-F141.
4. Mitchell KD, Navar LG. Intrarenal actions of angiotensin II in the pathogenesis of experimental hypertension. In: Hypertension: Pathophysiology, Diagnosis, and Management, ed 2. New York, NY: Raven Press; 1995:1437-1450.
5. Zou L-X, Imig JD, Von Thun AM, Hymel A, Ono H, Navar LG. Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II-infused rats. Hypertension. 1996;28:669-677.
6. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM. Renal injury from angiotensin II-mediated hypertension. Hypertension. 1992;19:464-474.
7. Casellas D, Dupont M. Kaskel FJ, Inagami T, Moore LC. Direct visualization of renin-cell distribution in preglomerular vascular trees dissected from rat kidney. Am J Physiol. 1993;265:F151-F156.
8. Bouriquet N, Dupont M, Herizi A, Mimran A, Casellas D. Preglomerular sudanophilia in L-NAME hypertensive rats: involvement of endothelin. Hypertension. 1996;27:382-391.
9. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
10. Cardona-Sanclemente LE, Medina R, Born GVR. Effect of increasing doses of angiotensin II infused into normal and hypertensive Wistar rats on low density lipoprotein and fibrinogen uptake by aortic walls. Proc Natl Acad Sci U S A. 1994:91:3285-3288.
11. Dohi Y, Hahn AWA, Boulanger CM, Bühler FR, Lüscher TF. Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension. 1992;19:131-137.
12. Aukland K, Øien AH. Renal autoregulation: models combining tubuloglomerular feedback and myogenic response. Am J Physiol. 1987;252:F768-F783.
13. Casellas D, Moore LC. Autoregulation and tubuloglomerular feedback in juxtamedullary glomerular arterioles. Am J Physiol. 1990;258:F660-F669.
14. Moore LC, Casellas D. Tubuloglomerular feedback dependence of autoregulation in rat juxtamedullary afferent arterioles. Kidney Int. 1990;37:1402-1408.
15. Carmines PK, Inscho EW, Gensure RC. Arterial pressure effects on preglomerular microvasculature of juxtamedullary nephrons. Am J Physiol. 1990:258:F94-F102.
16. Bidani AK, Schwartz MM, Lewis EJ. Renal autoregulation and vulnerability to hypertensive injury in remnant kidney. Am J Physiol. 1987;252:F1003-F1010.
17. Bidani AK, Griffin KA, Plott W, Schwartz MM. Renal ablation acutely transforms 'benign' hypertension to 'malignant' nephrosclerosis in hypertensive rats. Hypertension. 1994;24:309-316.
18. Griffin KA, Picken MM, Bidani AK. Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys. J Clin Invest. 1995;96:793-800.
19. Huang C, Davis G, Johns EJ. Effect of nitrendipine on autoregulation of perfusion in the cortex and papilla of kidneys from Wistar and stroke prone spontaneously hypertensive rats. Br J Pharmacol. 1994;111:111-116.
20. Takenaka T, Forster H, De Micheli A, Epstein M. Impaired myogenic responsiveness of renal microvessels in Dahl salt-sensitive rats. Circ Res. 1992;71:471-480.
21. Inscho EW, Carmines PK, Cook AK, Navar LG. Afferent arteriolar responsiveness to altered perfusion pressure in renal hypertension. Hypertension. 1990;15:748-752.
22. Bouriquet N, Casellas D. Chronic L-NAME hypertension in rats and autoregulation of juxtamedullary preglomerular vessels. Am J Physiol. 1995;269:F190-F197.
23. Ichihara A, Inscho EW, Imig JD, Michel RE, Navar LG. Role of renal nerves in afferent arteriolar reactivity in angiotensin-induced hypertension. Hypertension. s1997;29:442-449.
24. Casellas D, Navar LG. In vitro perfusion of juxtamedullary nephrons in rats. Am J Physiol. 1984;246:F349-F358.
25. Casellas D, Moore LC. Autoregulation of intravascular pressure in preglomerular juxtamedullary vessels. Am J Physiol. 1993;264: F315-F321.
26. Lapinski R, Perico N, Remuzzi A, Sangalli F, Benigni A, Remuzzi G. Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney. J Am Soc Nephrol. 1996;7:653-660.
27. Bohrer MP, Deen WM, Robertson CR, Brenner BM. Mechanism of angiotensin II-induced proteinuria in the rat. Am J Physiol. 1977;233:F13-F21.
28. Kurki P, Vanderlaan M, Dolbeare F, Gray J, Tan EM. Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp Cell Res. 1986;166:209-219.
29. Casellas D, Bouriquet N. Nimodipine-resistant tone in myogenically active preglomerular arteries of rat kidneys. Acta Physiol Scand. 1994;152:345-347
30. Kimura K, Suzuki N, Ohha S, Nagai R, Hiroi J, Mise N, Tojo A, Nagaoka A, Hirata Y, Goto A, Yazaki Y, Omata M, Hypertensive glomerular damage as revealed by the expression of α-smooth muscle actin and non-muscle myosin. Kidney Int. 1996;49(suppl 55):S-169-S-172.
31. Kowala MC, Rose PM, Stein PD, Goller N, Recce R, Beyer S, Valentine M, Barton D, Durham SK. Selective blockade of the endothelin subtype A receptor decreases early atherosclerosis in hamsters fed cholesterol. FASEB J. 1995;9:A854. Abstract.
32. Herizi A, Jover B, Mimran A. Rôle de l'endothéline dans l'hypertension artérielle induite par infusion de l'angiotensine II chez le rat. Arch Mal Coeur Vaiss. 1996;89:8. Abstract.
33. A-receptor blockade in angiotensin II-induced hypertension. Hypertension. 1997;29:435-441.
34. Jahan H, Kobayashi S, Nishimura J, Kanaide H. Endothelin-1 and angiotensin II act as progression but not competence growth factors in vascular smooth muscle cells. Eur J Pharmacol. 1996;295: 261-269.
35. Holstein-Rathlou N-H, Marsh DJ. Renal blood flow regulation and arterial pressure fluctuations: a case study in nonlinear dynamics. Physiol Rev. 1994;74:637-681.
36. Huelsemann JL, Sterzel RB, McKenzie DE, Wilcox CS. Effects of a calcium entry blocker on blood pressure and renal function during angiotensin-induced hypertension. Hypertension. 1985;7:374-379.
37. Li Q, Dale WE, Hasser EM, Blaine EH. Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency. Am J Physiol. 1996;271:R200-R207.
38. Ando K, Sato Y, Fujita T. Salt sensitivity in hypertensive rats with angiotensin II administration. Am J Physiol. 1990;259: R1012-R1016.
39. Larivière R, Thibault G, Schiffrin EL. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension. 1993;21:294-300.
40. Li J-S, Larivière R, Schiffrin EL. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats: evidence for a role of endothelin in vascular hypertrophy. Hypertension. 1994;24:183-188.
41. Sventek P, Li J-S, Grove K, Deschepper CF, Schiffrin EL. Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats. Hypertension. 1996;27:49-55.